ADAPTIMMUNE THERAPEUTICS PLC Operating Cash Flow
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Operating Cash Flow of -$101.37 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-08-13
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$34.78M, a 173.38% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$66.59M.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$34.20M.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$54.45M.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) operating activities for fiscal 2024 was -$73.21M.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) operating activities for fiscal 2023 was -$140.88M.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) operating activities for fiscal 2022 was -$141.77M, a 1421.36% decline from fiscal 2021.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) operating activities for fiscal 2021 was $10.73M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$34.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$101.37M 10-Q · filed 2025-08-13 | -$135.58M derived: sum of 3 quarters · filed 2025-08-13 | -$190.03M derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | -$66.59M 10-Q · filed 2025-05-13 | -$100.80M derived: sum of 2 quarters · filed 2025-05-13 | -$155.25M derived: sum of 3 quarters · filed 2025-05-13 | -$107.85M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-12-31 | -$34.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$88.66M derived: sum of 2 quarters · filed 2025-03-24 | -$41.26M derived: sum of 3 quarters · filed 2025-08-13 | -$73.21M 10-K · filed 2025-03-24 |
| 2024-09-30 | -$54.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$7.05M derived: sum of 2 quarters · filed 2025-08-13 | -$39.00M 10-Q · filed 2024-11-13 | -$53.68M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-06-30 | $47.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $15.45M 10-Q · filed 2025-08-13 | $773.00K derived: sum of 3 quarters · filed 2025-08-13 | -$44.39M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$31.95M 10-Q · filed 2025-05-13 | -$46.63M derived: sum of 2 quarters · filed 2025-05-13 | -$91.78M derived: sum of 3 quarters · filed 2025-05-13 | -$135.55M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$14.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$59.84M derived: sum of 2 quarters · filed 2025-03-24 | -$103.60M derived: sum of 3 quarters · filed 2025-03-24 | -$140.88M 10-K · filed 2025-03-24 |
| 2023-09-30 | -$45.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$88.92M derived: sum of 2 quarters · filed 2024-11-13 | -$126.20M 10-Q · filed 2024-11-13 | -$124.16M derived: sum of 4 quarters · filed 2025-03-24 |
| 2023-06-30 | -$43.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$81.05M 10-Q · filed 2024-08-12 | -$79.00M derived: sum of 3 quarters · filed 2025-03-24 | -$127.16M derived: sum of 4 quarters · filed 2025-03-24 |
| 2023-03-31 | -$37.28M 10-Q · filed 2024-05-15 | -$35.24M derived: sum of 2 quarters · filed 2025-03-24 | -$83.40M derived: sum of 3 quarters · filed 2025-03-24 | -$124.65M derived: sum of 4 quarters · filed 2025-03-24 |
| 2022-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$46.12M derived: sum of 2 quarters · filed 2025-03-24 | -$87.37M derived: sum of 3 quarters · filed 2025-03-24 | -$141.77M 10-K · filed 2025-03-24 |
| 2022-09-30 | -$48.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$89.41M derived: sum of 2 quarters · filed 2023-11-08 | -$143.81M 10-Q · filed 2023-11-08 | -$9.88M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-06-30 | -$41.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$95.65M 10-Q · filed 2023-08-09 | $38.28M derived: sum of 3 quarters · filed 2024-03-06 | -$6.92M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-03-31 | -$54.40M 10-Q · filed 2023-05-12 | $79.53M derived: sum of 2 quarters · filed 2024-03-06 | $34.33M derived: sum of 3 quarters · filed 2024-03-06 | $2.87M derived: sum of 4 quarters · filed 2024-03-06 |
| 2021-12-31 | $133.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $88.73M derived: sum of 2 quarters · filed 2024-03-06 | $57.27M derived: sum of 3 quarters · filed 2024-03-06 | $10.73M 10-K · filed 2024-03-06 |
| 2021-09-30 | -$45.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$76.66M derived: sum of 2 quarters · filed 2022-11-08 | -$123.20M 10-Q · filed 2022-11-08 | -$152.41M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | -$31.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$78.00M 10-Q · filed 2022-08-04 | -$107.22M derived: sum of 3 quarters · filed 2023-03-06 | -$123.53M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | -$46.54M 10-Q · filed 2022-05-09 | -$75.76M derived: sum of 2 quarters · filed 2023-03-06 | -$92.07M derived: sum of 3 quarters · filed 2023-03-06 | -$116.99M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | -$29.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$45.53M derived: sum of 2 quarters · filed 2023-03-06 | -$70.45M derived: sum of 3 quarters · filed 2023-03-06 | -$53.59M 10-K · filed 2023-03-06 |
| 2020-09-30 | -$16.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$41.23M derived: sum of 2 quarters · filed 2021-11-04 | -$24.38M 10-Q · filed 2021-11-04 | -$36.90M derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-06-30 | -$24.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$8.06M 10-Q · filed 2021-08-09 | -$20.59M derived: sum of 3 quarters · filed 2022-03-14 | -$50.19M derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-03-31 | $16.86M 10-Q · filed 2021-05-06 | $4.33M derived: sum of 2 quarters · filed 2022-03-14 | -$25.28M derived: sum of 3 quarters · filed 2022-03-14 | -$59.45M derived: sum of 4 quarters · filed 2022-03-14 |
| 2019-12-31 | -$12.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | -$42.14M derived: sum of 2 quarters · filed 2022-03-14 | -$76.30M derived: sum of 3 quarters · filed 2022-03-14 | -$112.51M 10-K · filed 2022-03-14 |
| 2019-09-30 | -$29.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$63.78M derived: sum of 2 quarters · filed 2020-11-05 | -$99.98M 10-Q · filed 2020-11-05 | -$131.66M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$34.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$70.37M 10-Q · filed 2020-08-06 | -$102.06M derived: sum of 3 quarters · filed 2021-02-25 | -$92.12M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$36.20M 10-Q · filed 2020-05-14 | -$67.89M derived: sum of 2 quarters · filed 2021-02-25 | -$57.95M derived: sum of 3 quarters · filed 2021-02-25 | -$93.31M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$31.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$21.75M derived: sum of 2 quarters · filed 2021-02-25 | -$57.11M derived: sum of 3 quarters · filed 2021-02-25 | -$104.39M 10-K · filed 2021-02-25 |
| 2018-09-30 | $9.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$25.42M derived: sum of 2 quarters · filed 2019-11-06 | -$72.70M 10-Q · filed 2019-11-06 | -$94.06M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | -$35.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$82.64M 10-Q · filed 2019-08-01 | -$104.00M derived: sum of 3 quarters · filed 2019-08-01 | -$90.51M derived: sum of 4 quarters · filed 2019-08-01 |
| 2018-03-31 | -$47.28M 10-Q · filed 2019-05-06 | -$68.64M derived: sum of 2 quarters · filed 2019-05-06 | -$55.15M derived: sum of 3 quarters · filed 2019-05-06 | -$73.16M derived: sum of 4 quarters · filed 2019-05-06 |
| 2017-12-31 | -$21.36M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$7.87M derived: sum of 2 quarters · filed 2019-02-27 | -$25.88M derived: sum of 3 quarters · filed 2019-02-27 | -$54.31M 10-K · filed 2019-02-27 |
| 2017-09-30 | $13.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$4.52M derived: sum of 2 quarters · filed 2018-11-06 | -$32.96M 10-Q · filed 2018-11-06 | -$30.59M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$18.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$46.45M 10-Q · filed 2018-08-02 | -$44.08M derived: sum of 3 quarters · filed 2019-02-27 | -$59.44M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$28.44M 10-Q · filed 2018-05-09 | -$26.07M derived: sum of 2 quarters · filed 2019-02-27 | -$41.44M derived: sum of 3 quarters · filed 2019-02-27 | |
| 2016-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$13.00M derived: sum of 2 quarters · filed 2019-02-27 | -$48.17M 10-K · filed 2019-02-27 | |
| 2016-09-30 | -$15.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$50.54M 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | -$35.17M 10-Q · filed 2017-08-03 | |||
| 2015-12-31 | -$18.06M 10-K · filed 2018-03-15 | |||
| 2015-06-30 | -$29.67M 10-K · filed 2018-03-15 |